NCDL - Nuveen Churchill Di... Stock Analysis | Stock Taper
Logo
Nuveen Churchill Direct Lending Corp.

NCDL

Nuveen Churchill Direct Lending Corp. NYSE
$12.88 -3.63% (-0.49)

Market Cap $635.86 M
52w High $17.71
52w Low $12.76
Dividend Yield 12.84%
Frequency Irregular
P/E 8.47
Volume 544.99K
Outstanding Shares 49.39M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $52.1M $14.02M $31.59M 60.63% $0.63 $60.98M
Q3-2025 $39.96M $2.92M $18.66M 46.69% $0.38 $18.66M
Q2-2025 $38.19M $2.96M $16.02M 41.93% $0.32 $15.92M
Q1-2025 $53.59M $7.74M $27.41M 51.16% $0.53 $48.09M
Q4-2024 $48.31M $-717K $29.45M 60.96% $0.54 $29.76M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $8.55M $2.05B $1.18B $875.18M
Q3-2025 $46.33M $2.04B $1.16B $881.49M
Q2-2025 $44.01M $2.07B $1.19B $887.74M
Q1-2025 $49.18M $2.17B $1.25B $920.02M
Q4-2024 $43.25M $2.14B $1.17B $970.32M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $18.66M $12.21M $25.05M $-34.93M $2.33M $12.21M
Q2-2025 $16.02M $56M $81.14M $-142.31M $-5.17M $56M
Q1-2025 $15.02M $-4.14M $-4.67M $14.68M $5.87M $-4.14M
Q4-2024 $29.45M $43.63M $-31.64M $-38.04M $-26.05M $43.63M
Q3-2024 $36.64M $-42.27M $0 $40.59M $-1.68M $-42.27M

What's strong about this company's cash flow?

The company is still generating cash from its core business, paid down debt, and increased its cash balance. There is no reliance on outside funding, and buybacks are modest and sustainable.

What are the cash flow concerns?

Operating and free cash flow fell dramatically from last quarter, and working capital changes hurt cash. The company also stopped paying dividends, which may signal caution.

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Nuveen Churchill Direct Lending Corp.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

NCDL combines strong initial profitability and cash generation with an exceptionally conservative balance sheet that currently carries no financial debt. It sits within a powerful institutional platform backed by Nuveen and TIAA, which supports sourcing, credibility, and execution. Operating expenses are low relative to revenue, and the company is already able to pay meaningful dividends and repurchase shares, suggesting that the core economics of the lending model are attractive at this stage. The focus on senior secured lending to sponsor‑backed, cash‑flow‑generating companies also provides a structurally safer profile than more speculative lending segments.

! Risks

Key risks stem from limited public operating history, heavy reliance on the credit performance of a largely opaque loan portfolio, and exposure to competitive and economic cycles in the direct lending market. The absence of retained earnings and the early stage of the listed entity mean there is little evidence yet of how the business performs across downturns. Strong distributions and aggressive investment activity have reduced cash on hand, so sustaining current payout levels will depend on continued strong cash generation. Over time, the introduction of leverage, shifts in underwriting standards, or deterioration in borrower quality could meaningfully alter the risk profile.

Outlook

Looking ahead, NCDL appears well positioned to benefit from ongoing demand for private credit and sponsor‑backed financing, especially given its integration with a scaled and reputable platform. If it maintains disciplined underwriting, prudent use of leverage, and balanced capital allocation between growth and distributions, its current financial strength could translate into durable earnings and cash flows. However, uncertainty remains elevated relative to more seasoned BDCs: future performance will be shaped by how the credit cycle unfolds, how competitive pressures affect pricing and terms, and how effectively management navigates growth without sacrificing resilience.